JP2024510500A5 - - Google Patents

Info

Publication number
JP2024510500A5
JP2024510500A5 JP2023557348A JP2023557348A JP2024510500A5 JP 2024510500 A5 JP2024510500 A5 JP 2024510500A5 JP 2023557348 A JP2023557348 A JP 2023557348A JP 2023557348 A JP2023557348 A JP 2023557348A JP 2024510500 A5 JP2024510500 A5 JP 2024510500A5
Authority
JP
Japan
Prior art keywords
indocyanine green
composition according
compound
aspects
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510500A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/056443 external-priority patent/WO2022194731A1/en
Publication of JP2024510500A publication Critical patent/JP2024510500A/ja
Publication of JP2024510500A5 publication Critical patent/JP2024510500A5/ja
Pending legal-status Critical Current

Links

JP2023557348A 2021-03-17 2022-03-14 インドシアニングリーンの安定な処方物 Pending JP2024510500A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21305322 2021-03-17
EP21305322.6 2021-03-17
PCT/EP2022/056443 WO2022194731A1 (en) 2021-03-17 2022-03-14 Stable formulations of indocyanine green

Publications (2)

Publication Number Publication Date
JP2024510500A JP2024510500A (ja) 2024-03-07
JP2024510500A5 true JP2024510500A5 (enExample) 2025-02-06

Family

ID=75302474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557348A Pending JP2024510500A (ja) 2021-03-17 2022-03-14 インドシアニングリーンの安定な処方物

Country Status (8)

Country Link
US (1) US20240299549A1 (enExample)
EP (1) EP4308082A1 (enExample)
JP (1) JP2024510500A (enExample)
KR (1) KR20230157389A (enExample)
CN (1) CN117062597B (enExample)
BR (1) BR112023018955A2 (enExample)
MX (1) MX2023010927A (enExample)
WO (1) WO2022194731A1 (enExample)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509260A (ja) * 1993-04-20 1996-10-01 マリンクロット・メディカル・インコーポレイテッド 電圧感受性染料の安定化
FR2710060B1 (fr) 1993-09-17 1995-11-17 Rech Biolog Et Procédé de préparation de benz[e]indoles substitués de pureté élevée et leurs sels alcalins.
US6944493B2 (en) 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
DE102007030403A1 (de) * 2007-06-29 2009-01-08 Universität Bielefeld Verfahren zur Verbesserung der Photostabilität von Fluoreszenzfarbstoffen
EP2036577A1 (de) * 2007-09-14 2009-03-18 mivenion GmbH Diagnostische Stoffe für die optische bildgebende Untersuchung auf der Basis von nanopartikulären Formulierungen
CN103301482B (zh) 2013-06-27 2014-12-17 深圳先进技术研究院 两亲性三嵌段聚多肽载icg胶束及其制备方法
KR101774859B1 (ko) * 2014-11-27 2017-09-06 (주) 씨유스킨 인도시아닌 그린-함유 조성물의 광민감제 및 이를 포함하는 조성물
JP6623479B2 (ja) 2015-02-08 2019-12-25 トンリ・バイオメディカル・カンパニー・リミテッド 脂質ナノ粒子及びその使用
DK3383436T3 (da) 2015-12-01 2023-11-20 Dishman Carbogen Amcis Ltd Forbedret fremgangsmåde til fremstilling af indocyaningrønt
US20190337896A1 (en) 2018-05-02 2019-11-07 Biophore India Pharmaceuticals Pvt. Ltd. PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)
WO2020240514A1 (en) 2019-05-30 2020-12-03 Leiutis Pharmaceuticals Pvt, Ltd. Stable formulations of indocyanine green
JP2024510501A (ja) * 2021-03-17 2024-03-07 プルーヴファーム・ライフ・ソリューションズ インドシアニングリーンの安定な処方物

Similar Documents

Publication Publication Date Title
KR890011823A (ko) 벤조일 페닐아세트산 유도체 약제 조성물
JPS61500468A (ja) 食品添加用組成物
JP6094388B2 (ja) ペメトレキセドを含む注射用組成物
US4020162A (en) Oxytetracycline solution for parenteral, peroral and local administration and processes for the production thereof
JPS6021570B2 (ja) ド−パ類の高濃度製剤の製法
JP2008542237A5 (enExample)
FI3817751T3 (fi) Vedettömän natriumtiosulfaatin formulaatioita
JP2004502743A (ja) 薬学的化合物の還元体の製造、安定化および使用
JP2004067682A (ja) 抗生物質活性を有する薬学的組成物
JP2024510501A5 (enExample)
JP2022514597A5 (enExample)
JP2021513521A5 (enExample)
JP2019526631A5 (enExample)
RU2017139874A (ru) Композиция для ухода за полостью рта
ES2946237T3 (es) Sistemas de dos componentes que comprenden ácido acetilsalicílico y una sal de carbonato
JP2024510302A5 (enExample)
JP2019502751A5 (enExample)
JP2005535644A5 (enExample)
JP2021119164A5 (enExample)
JP2003339853A (ja) 安定な透析用剤
TWI285105B (en) The composition of lipoperoxide reducing agent
PT695544E (pt) Capsulas de gelatina dura resistentes a desnaturacao e sua producao
JP2010504971A5 (enExample)
RU2238720C1 (ru) Фармацевтический водный раствор для инъекций
RU2011134414A (ru) Комбинация фульвовой кислоты для лечения различных состояний и болезней